Sivaprakash Ramalingam
Mathura Road
New Delhi, DL 110025, India
New Delhi, DL 110025, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Pattern of pituitary gland injuries in fatal head injuries: A cross-sectional autopsy study.
Journal: Journal of forensic and legal medicine
Published: June 08, 2026
MicroRNA-195-5p/E2F7 Axis Underlies the Antimicrobial Additive Triclosan-Induced Cytotoxicity in Human Pulmonary Epithelial Cells.
Journal: Journal of applied toxicology : JAT
Published: May 11, 2026
Feasibility of tuberculosis drug-induced liver injury screening under programme settings in Southern India.
Journal: Public health action
Published: March 30, 2026
Mutations in KAT3 family of lysine acetyl transferases impair neural crest migration in Rubinstein Taybi syndrome models.
Journal: Developmental dynamics : an official publication of the American Association of Anatomists
Published: December 29, 2025
AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape.
Journal: Nature communications
Published: July 20, 2025
CRISPR-mediated generation of a tumor-associated antigen-deficient Raji platform to investigate antigen loss in CAR-T cell therapy.
Journal: Frontiers in genome editing
Published: June 19, 2025
Arsenic Induces Cytotoxicity in Pulmonary Epithelial Cells by Regulating the MicroRNA-195-5p/E2F7 Axis: The Impact of Tannic Acid From Natural Sources.
Journal: Journal of applied toxicology : JAT
Published: May 25, 2025
CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.
Journal: Stem cell research & therapy
Published: April 23, 2025
Exploring potential allosteric activators of pyruvate Kinase: Insights from molecular docking, DFT and dynamics simulation studies.
Journal: Computers in biology and medicine
Published: February 06, 2025
A critique review of fetal hemoglobin modulators through targeting epigenetic regulators for the treatment of sickle cell disease.
Journal: Life sciences
Published: January 02, 2025
Last Updated: 09/26/2026